Evidence map›Paper›PMID 31620113›Full record

ReviewFrontiers in microbiology2019

Hans Carolus, Katrien Van Dyck, Patrick Van Dijck

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Virulence · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. The metabolic trap:Journal of medical microbiology · 2026
    Article
  7. Article
  8. Article
  9. Copper-driven mutualism ofMicrobiology (Reading, England) · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Confronting the "lethal duo" in the ICU: early identification ofFrontiers in cellular and infection microbiology · 2026
    Observational
  14. Differences in Clinical Characteristics of AECOPD Patients with or withoutInternational journal of chronic obstructive pulmonary disease · 2026
    Article
  15. Article
  16. MixedJournal of fungi (Basel, Switzerland) · 2025
    Article
  17. Control ofFuture microbiology · 2025
    Article
  18. Article
  19. Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hans CarolusLaboratory of Molecular Cell Biology, Department of Biology, Institute of Botany and Microbiology, KU Leuven, Leuven, Belgium.
Katrien Van DyckLaboratory of Molecular Cell Biology, Department of Biology, Institute of Botany and Microbiology, KU Leuven, Leuven, Belgium.
Patrick Van DijckLaboratory of Molecular Cell Biology, Department of Biology, Institute of Botany and Microbiology, KU Leuven, Leuven, Belgium.

Funding

C. albicans and S. aureus Catheter Infections: Clinical Implications and TherapyR01AI130170 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI JABRA-RIZK, MARY ANN Y · 2017 to 2020
$1.5M
NIAID NIH HHS R01 AI130170
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biofilmsCandida albicansinterkingdom interactionsinterspecies interactionspolymicrobial infectionsStaphylococcus aureusStaphylococcus epidermidis

Identifiers

PMID31620113
PMCPMC6759544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.